Loading
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Jul 2026 for Aytu Biopharma, INC.
Filing timeline
BuySaleJarrett Disbrow
Insider track record
Disclosed buys
5
Disclosed sells
0
Signal history
Closed purchases
Market purchases
5
Positive at T+90
20%
Median T+90
-20.0%
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +13.5%Entry US$1.93 · Close at T+365 US$2.19
- -82.4%Entry US$1,600.00 · Close at T+365 US$282.00
- -85.5%Entry US$96,000.00 · Close at T+365 US$13,880.00
- -85.3%Entry US$364,800.00 · Close at T+365 US$53,600.00
- -89.2%Entry US$777,600.00 · Close at T+365 US$84,000.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jarrett Disbrow: trading record in brief
Jarrett Disbrow appears in our data through filings on Aytu Biopharma, Inc shares, published by SEC (Form 4). Over a trading history stretching from 20 January 2016 to 28 July 2026, the count stands at 14 filings.
Every open-market trade on record is a purchase: 5 purchases worth €510k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 8 share grants and 1 option exercise.
A typical purchase (the median) is worth €88k. Of 5 purchases, 5 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 5 purchases show a median change of -20.0%, with the price up in 20% of them. Past outcomes like these are no guarantee of what comes next.
On 30 July 2026 came the latest disclosure, a share grant in Aytu Biopharma, Inc. The most recent open-market purchase was published on 10 June 2025, 501 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jarrett Disbrow
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
15,000 shares0Common StockSEC:0001437749-26-025081:0
19,606 shares0Common StockSEC:0001437749-25-030648:0
12,500 shares0Common StockSEC:0001437749-25-030648:1
16,666 shares@ US$1.50100.0% of flowCommon StockSEC:0001437749-25-019958:0
Canonical exit: 7 Sept 2025 (T+90)
337,500 sharesCommon StockSEC:0001213900-18-014530:0
226,105 shares@ US$0.459.6% of flowCommon StockSEC:0001213900-18-002654:0
Canonical exit: 4 Jun 2018 (T+90)
100,000 sharesCommon StockSEC:0001213900-17-011708:0
1,666,667 shares@ US$0.1524.9% of flowCommon StockSEC:0001638599-17-000786:0
187,500 shares@ US$0.7515.6% of flowCommon StockSEC:0001638599-17-000230:0
166,666 shares@ US$1.5026.4% of flowCommon StockSEC:0001638599-16-001507:0
Canonical exit: 31 Jan 2017 (T+90)
48,184 shares0Common StockSEC:0001209191-16-135483:0
165,000 shares0Common StockSEC:0001209191-16-132312:0
250,000 shares@ US$0.4010.2% of flowCommon StockSEC:0001209191-16-120342:0
Canonical exit: 4 Aug 2016 (T+90)
153,846 shares@ US$0.6580.7% of flowCommon StockSEC:0001209191-16-092878:0
Canonical exit: 19 Apr 2016 (T+90)
14 of 14 declarations
